Figure 4.

Matrix metalloproteinases are required for COL4A2 incorporation, basement membrane expansion and hair follicle morphogenesis. (A) Schematic of the experimental procedure for MMP inhibition. (B) Snapshot images of eGFP-COL4A2 FRAP experiments in follicles from eGFP-Col4a2 explants, with or without MMP inhibitor. eGFP-COL4A2 (green) recovery after photobleaching is shown at the tip (blue arrowheads), lower stalk (orange arrowheads), and junction (gray arrowheads) regions in control and MMP-inhibited follicles (open arrowheads). Scale bar: 20 μm. (C) Normalized mean intensity values of eGFP-COL4A2 in bleached regions (n = 6 follicles, each from a separate explant in an independent experiment for the control, and n = 6 follicles from four explants, each from an independent experiment for the inhibitor-treated condition). Values normalized to 0 h. MMPi = MMP inhibitor treatment. Values: means ± SD. The control data of this experiment are shown in Fig. 3 B. (D) Quantification of the mean intensity at 3 h 30 min in C. Values: means ± SD. Two-tailed unpaired t tests were used. (E) BM length changes during the early stage of MMP inhibition (0–7 h) (n = 8 follicles from four explants, each from an independent experiment for the control, and n = 12 follicles from four explants, each from an independent experiment for the inhibitor-treated). Re-photobleaching of the targeted BM was performed every 2–3 h. Values: means ± SD. Two-way ANOVA with Tukey’s post-hoc tests was used. (F) BM length changes during the later stage of MMP inhibition (16–23 h) (n = 9 follicles from six explants, each from an independent experiment for the control, and n = 5 follicles from three explants, each from an independent experiment for the inhibitor-treated). Re-photobleaching of the targeted BM was performed. Values: means ± SD. Two-tailed unpaired t tests were used. The control data of this experiment are shown in Fig. 2 C. (G–O) Morphological changes in follicles during the early stage of MMP inhibition (0–16 h). (G) Confocal images. (H) Shape factor: S = follicle length (LHF)/bulb width (WHF). Changes in the length of follicles (I), the normalized length (J), width (K), normalized width (L), shape factor changes (M), shape factor at 0 h (N), and at 16 h (O) (n = 10 follicles from five explants, each from an independent experiment for the control, and n = 14 follicles from four explants, each from an independent experiment for the inhibitor-treated). The values were normalized to 0 h (J and L). Values: means ± SD. Two-tailed unpaired t tests were used. Two-way ANOVA with Tukey’s post-hoc tests was used for J and L. Scale bars: 20 μm. (P–U) Morphological changes during the later stage of MMP inhibition (16–36 h). (P) Confocal images. Changes in follicle length (Q), width (R), width at 16 h (S), shape factor changes (T), and shape factor at 36 h (U). (n = 8 follicles from seven explants, each from an independent experiment for the control, and n = 8 follicles from five explants, each from an independent experiment for the inhibitor-treated). Values: means ± SD. Two-tailed unpaired t tests were used. Scale bars: 20 μm. All statistical tests in this figure assumed normal data distribution, but this was not formally tested.

or Create an Account

Close Modal
Close Modal